BridgeMD
New treatment option for Aortic Dissection
Official title Scandinavian Trial of Uncomplicated Aortic Dissection Therapy
ClinicalTrials.gov ID: NCT05215587
What this study is testing
- What it's testing
- The introduction of thoracic endovascular aortic repair (TEVAR) in 1994 has radically changed the treatment of thoracic aortic pathology, and TEVAR is now the recommended therapy for "complicated" TBADs and other thoracic aorta diseases. To date, the use of TEVAR in the treatment of "uncomplicated" dissections (uTBAD) is uncertain, although it is presumed that a prophylactic procedure can prevent later complex surgery and early death.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All people, aged 18 or greater at the time of informed consent, admitted or referred to the participating vascular surgery site with an uTBAD of less...
You likely can't join if
- people with no signed informed consent.
- people presenting with a complicated type B aortic dissection according to the above definition.
- people previously treated in their descending aorta, either open surgery or TEVAR.
- people with pre-existing thoracoabdominal aortic aneurysm.
- people with other aortic pathology with an indication for intervention that requires TEVAR.
- people with traumatic aortic dissections.
See the full eligibility criteria
- All people, aged 18 or greater at the time of informed consent, admitted or referred to the participating vascular surgery site with an uTBAD of less than four weeks duration.
- people with no signed informed consent.
- people presenting with a complicated type B aortic dissection according to the above definition.
- people previously treated in their descending aorta, either open surgery or TEVAR.
- people with pre-existing thoracoabdominal aortic aneurysm.
- people with other aortic pathology with an indication for intervention that requires TEVAR.
- people with traumatic aortic dissections.
- people with an established connective tissue disease at the time of randomization, including but not limited to Marfans and Loeys-Dietz syndrome.
- people with a clinically estimated life expectancy \< 2 years.
- people with dementia.
- Pregnant or nursing people.
- people with current sepsis.
- people currently participating in other clinical treatment trials.
The study team makes the final eligibility decision.
Where it's taking place
- Aalborg, Denmark
- Aarhus, Denmark
- Copenhagen, Denmark
- Odense, Denmark
- Helsinki, Finland
- Kuopio, Finland
- Oulu, Finland
- Tampere, Finland
- Turku, Finland
- Reykjavik, Iceland
- Amsterdam, Netherlands
- Groningen, Netherlands
- Leiden, Netherlands
- Maastricht, Netherlands
- Nijmegen, Netherlands
- Rotterdam, Netherlands
- Utrecht, Netherlands
- Bergen, Norway
- Oslo, Norway
- Tromsø, Norway
+ 7 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aalborg, Denmark; Aarhus, Denmark; Copenhagen, Denmark; Odense, Denmark; Helsinki, Finland; Kuopio, Finland and 21 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.